A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells
出版年份 2016 全文链接
标题
A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells
作者
关键词
Bispecific antibody, Single domain antibody, Her2, CD16, Fab, Bacterial expression
出版物
AMB Express
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-04-26
DOI
10.1186/s13568-016-0201-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Novel Bispecific Antibody, S-Fab, Induces Potent Cancer Cell Killing
- (2015) Li Li et al. JOURNAL OF IMMUNOTHERAPY
- A FcγRIII-engaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy
- (2015) Marc Turini et al. Oncotarget
- Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells
- (2014) T. T. Junttila et al. CANCER RESEARCH
- Functional expression of a single-chain antibody fragment against human epidermal growth factor receptor 2 (HER2) in Escherichia coli
- (2014) Vajihe Akbari et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- Purified anti-CD3 × anti-HER2 bispecific antibody potentiates cytokine-induced killer cells of poor spontaneous cytotoxicity against breast cancer cells
- (2014) Qingzhong He et al. Cell and Bioscience
- Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies
- (2013) Christoph Spiess et al. NATURE BIOTECHNOLOGY
- Generation and characterization of new HER2 monoclonal antibodies
- (2012) Flávia Aleixo Vasconcellos et al. ACTA HISTOCHEMICA
- A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens
- (2012) Gregory L. Moore et al. mAbs
- Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells
- (2011) Silvia Sommaruga et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Superior In vivo Efficacy of Afucosylated Trastuzumab in the Treatment of HER2-Amplified Breast Cancer
- (2010) Teemu T. Junttila et al. CANCER RESEARCH
- Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2009) Neil L. Spector et al. JOURNAL OF CLINICAL ONCOLOGY
- Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: Relevance of receptor endocytosis
- (2009) T. Ben-Kasus et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-HER2 Treatment and Breast Cancer: State of the Art, Recent Patents, and New Strategies
- (2009) Lorenzo Daniele et al. Recent Patents on Anti-Cancer Drug Discovery
- Single-domain antibody fragments with high conformational stability
- (2002) Mireille Dumoulin et al. PROTEIN SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started